CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus. 2018

Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

CD47 is a ubiquitous cell surface receptor that directly regulates T cell immunity by interacting with its inhibitory ligand thrombospondin-1 and limits clearance of cells by phagocytes that express its counter-receptor signal-regulatory protein-α. Murine natural killer (NK) cells express higher levels of CD47 than other lymphocytes, but the role of CD47 in regulating NK cell homeostasis and immune function remains unclear. Cd47-/- mice exhibited depletion of NK precursors in bone marrow, consistent with the antiphagocytic function of CD47. In contrast, antisense CD47 knockdown or gene disruption resulted in a dose dependent accumulation of immature and mature NK cells in spleen. Mature Cd47-/- NK cells exhibited increased expression of NK effector and interferon gene signatures and an increased proliferative response to interleukin-15 in vitro. Cd47-/- mice showed no defect in their early response to acute Armstrong lymphocytic choriomeningitis virus (LCMV) infection but were moderately impaired in controlling chronic Clone-13 LCMV infection, which was associated with depletion of splenic NK cells and loss of effector cytokine and interferon response gene expression in Cd47-/- NK cells. Broad CD47-dependent differences in NK activation, survival, and exhaustion pathways were observed in NK cell transcriptional signatures in LCMV infected mice. These data identify CD47 as a cell-intrinsic and systemic regulator of NK cell homeostasis and NK cell function in responding to a viral infection.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008216 Lymphocytic Choriomeningitis A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3) Armstrong Syndrome,Armstrong's Syndrome,Encephalomyelitis, Lymphocytic Choriomeningitis Virus,Lymphocytic Choriomeningitis Virus Encephalomyelitis,Choriomeningitis, Lymphocytic,Syndrome, Armstrong,Syndrome, Armstrong's
D008217 Lymphocytic choriomeningitis virus The type species of ARENAVIRUS, part of the Old World Arenaviruses (ARENAVIRUSES, OLD WORLD), producing a silent infection in house and laboratory mice. In humans, infection with LCMV can be inapparent, or can present with an influenza-like illness, a benign aseptic meningitis, or a severe meningoencephalomyelitis. The virus can also infect monkeys, dogs, field mice, guinea pigs, and hamsters, the latter an epidemiologically important host. LCM Viruses,LCMV,LCM Virus,Lymphocytic choriomeningitis viruses
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
January 1980, Scandinavian journal of immunology,
Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
December 1991, The Journal of experimental medicine,
Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
October 1977, Journal of immunology (Baltimore, Md. : 1950),
Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
April 1986, Immunology,
Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
November 2001, Journal of virology,
Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
January 1995, Springer seminars in immunopathology,
Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
February 1979, Journal of immunology (Baltimore, Md. : 1950),
Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
October 1995, International immunology,
Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
July 1978, The Journal of experimental medicine,
Pulak Ranjan Nath, and Arunakumar Gangaplara, and Dipasmita Pal-Nath, and Ajeet Mandal, and Dragan Maric, and John M Sipes, and Maggie Cam, and Ethan M Shevach, and David D Roberts
July 2009, Memorias do Instituto Oswaldo Cruz,
Copied contents to your clipboard!